The goal of this systematic review is to update the 2011 ECDC risk assessment. Evidence from this review will be used to develop guidance on this topic.
This systematic review seeks to identify evidence for the effectiveness of targeted infection control measures to control the spread and transmission of ESBL-E when transferring patients between healthcare settings, especially when the transfer is cross-border.
This report presents the results of the fifth round of the external quality assessment scheme for typing of verocytotoxin-producing E. coli (VTEC) (further EQA-5) funded by ECDC.
From 21 to 28 November 2014, nearly 700 organisations across Europe will host activities to increase awareness of the personal and public health benefits of HIV testing. As HIV infection can remain asymptomatic for a long time and a substantial number of infected persons across Europe are unaware of their infection, ECDC supports the aims of this second European HIV testing week.
ECDC gathered guidance documents on prevention and control of infection with carbapenem-resistant Enterobacteriaceae (CRE) available online, published by EU/EEA Member States, ECDC, other agencies and scientific societies.
Monitoring and responding to HIV and hepatitis C among people who inject drugs is the focus of two new reports from the EU drugs agencies EMCDDA and ECDC.
This report presents the results of the fourth round of the VTEC external quality assessment scheme for the typing of verocytotoxin-producing E. coli (VTEC).
This report presents the results of the third round of the VTEC external quality assessment scheme for the typing of verocytotoxin-producing E. coli (VTEC).